A YouTuber has received an unexpected visit from the police over an automatic license plate recognition (ALPR) camera he built to specifically track police cars, using the same technology law enforcement has infamously used to track ordinary citizens. In a video posted to his channel on October 7, Anthony Sistilli says two police officers showed up at his doorstep on September 20th to ask questions about the device, asking what his intentions were with the project.

Sistilli, a Canadian software engineer and YouTuber, pointed out the irony of the officers' concerns, explaining that they mirror the privacy concerns of ordinary citizens who are growing increasingly weary of the recent spike in blanket surveillance brought about by a mass installation of ALPR cameras. Flock Safety, a U.S. public safety technology company, recently scaled its centralized national surveillance network to over 120,000 cameras operating across 49 states, according to the company, capturing billions of vehicle scans every month.

A federal judge in Alabama ordered immigration officers to stop warrantless raids of construction sites, to stop detaining construction workers without a reason to suspect that a specific individual is undocumented, and to immediately release workers who present evidence of lawful presence like a REAL ID.

The stay of these policies comes in a class-action lawsuit brought by Leo Garcia Venegas, who is represented by the Institute for Justice.

In this episode of The Drive, Peter explores how seemingly obscure basic science discoveries have laid the foundation for some of the most important medical breakthroughs of the past half century. Rather than focusing on the clinical applications of modern therapies, he traces the fascinating stories behind the scientists, experiments, and unexpected discoveries that ultimately led to transformative drug classes, revealing how groundbreaking advances often emerge from research with no obvious clinical goal. Through these historical case studies, Peter provides a new perspective on the unpredictable path of medical innovation and makes the case for why investing in basic scientific research remains essential for driving the next generation of life-changing therapies.